Eyepoint Pharmaceuticals (EYPT) had the highest return in 2023 by a US stock in the Pharmaceuticals Industry, returning 551%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Eyepoint Pharmaceuticals (EYPT) | 2023 | 550.99% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2023 | 196.1% |
Verrica Pharmaceuticals (VRCA) | 2023 | 157.75% |
Iterum Therapeutics (ITRM) | 2023 | 134.52% |
Aquestive Therapeutics (AQST) | 2023 | 125.7% |
Amphastar P (AMPH) | 2023 | 120.81% |
Avadel Pharmaceuticals (AVDL) | 2023 | 104.34% |
Liquidia Technologies (LQDA) | 2023 | 88.85% |
Xeris Pharmaceuticals (XERS) | 2023 | 85.04% |
Context Therapeutics (CNTX) | 2023 | 73.85% |
Eli Lilly and (LLY) | 2023 | 60.72% |
Corcept Therapeutics (CORT) | 2023 | 59.22% |
Ocular Therapeutix (OCUL) | 2023 | 55.4% |
Eton Pharmaceuticals (ETON) | 2023 | 53.15% |
Novo Nordisk A-S (NVO) | 2023 | 52.66% |
Scynexis (SCYX) | 2023 | 41.14% |
Omeros (OMER) | 2023 | 39.15% |
Evolus (EOLS) | 2023 | 38.92% |
Tarsus Pharmaceuticals (TARS) | 2023 | 38.6% |
Dr Reddy’s Laboratories Ltd ADR (RDY) | 2023 | 36.5% |
ANI Pharmaceuticals (ANIP) | 2023 | 34.98% |
Zoetis (ZTS) | 2023 | 33.98% |
Collegium Pharmaceutical (COLL) | 2023 | 31.76% |
Bausch Health Companies (BHC) | 2023 | 27.1% |
Novartis AG ADR (NVS) | 2023 | 22.52% |
